$STRO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SUTRO BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SUTRO BIOPHARMA, INC.. Get notifications about new insider transactions in SUTRO BIOPHARMA, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | Lobacki Joseph M | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 | |
| Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | JANNEY DANIEL | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 | |
| Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | Freund John Gordon | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 | |
| Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | Dybbs Michael | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 | |
| Jan 31 2019 | STRO | SUTRO BIOPHARMA, I ... | Worsley Stephen | Chief Business Offi ... | Option Exercise | A | 10.45 | 30,000 | 313,500 | 30,000 | |
| Jan 31 2019 | STRO | SUTRO BIOPHARMA, I ... | NEWELL WILLIAM J | CEO | Option Exercise | A | 10.45 | 445,000 | 4,650,250 | 445,000 | |
| Jan 31 2019 | STRO | SUTRO BIOPHARMA, I ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | A | 10.45 | 47,500 | 496,375 | 47,500 | |
| Jan 31 2019 | STRO | SUTRO BIOPHARMA, I ... | Hallam Trevor | Chief Science Offic ... | Option Exercise | A | 10.45 | 47,500 | 496,375 | 47,500 | |
| Jan 31 2019 | STRO | SUTRO BIOPHARMA, I ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | A | 10.45 | 30,000 | 313,500 | 30,000 | |
| Jan 31 2019 | STRO | SUTRO BIOPHARMA, I ... | Shabbir Anik | Chief Technical Ops ... | Option Exercise | A | 10.45 | 35,000 | 365,750 | 35,000 | |
| Jan 31 2019 | STRO | SUTRO BIOPHARMA, I ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | A | 10.45 | 47,500 | 496,375 | 47,500 | |
| Nov 13 2018 | STRO | SUTRO BIOPHARMA, I ... | Sharp Shalini | Director | Option Exercise | A | 14.23 | 26,033 | 370,450 | 26,033 | |
| Oct 03 2018 | STRO | SUTRO BIOPHARMA IN ... | Skyline Venture Partners V LP | 10% Owner | Option Exercise | C | 0.00 | 18,698,578 | 0 | 0 | |
| Oct 03 2018 | STRO | SUTRO BIOPHARMA IN ... | Skyline Venture Partners V LP | 10% Owner | Option Exercise | C | 0.00 | 12,846,023 | 0 | 0 | |
| Oct 03 2018 | STRO | SUTRO BIOPHARMA IN ... | Skyline Venture Partners V LP | 10% Owner | Option Exercise | C | 0.00 | 25,015,635 | 0 | 0 | |
| Oct 03 2018 | STRO | SUTRO BIOPHARMA IN ... | Skyline Venture Partners V LP | 10% Owner | Buy | C | 0.00 | 514,211 | 0 | 1,960,053 | 1.4 M to 2 M (+35.56 %) |
| Oct 03 2018 | STRO | SUTRO BIOPHARMA IN ... | Skyline Venture Partners V LP | 10% Owner | Buy | C | 0.00 | 520,264 | 0 | 1,445,842 | 925.6 K to 1.4 M (+56.21 %) |
| Oct 03 2018 | STRO | SUTRO BIOPHARMA IN ... | Skyline Venture Partners V LP | 10% Owner | Buy | C | 0.00 | 925,578 | 0 | 925,578 | 0 to 925.6 K |
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 18,726,075 | 0 | 0 | ||
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 18,097,331 | 0 | 0 | ||
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 2,845,114 | 0 | 0 | ||
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Option Exercise | C | 0.00 | 8,338,892 | 0 | 0 | ||
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | CELGENE CORP /DE/ | Buy | C | 0.00 | 1,726,197 | 0 | 1,726,197 | 0 to 1.7 M | |
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | Merck & Co., Inc. | 10% Owner | Option Exercise | C | 0.00 | 74,794,315 | 0 | 0 | |
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | Merck & Co., Inc. | 10% Owner | Buy | P | 15.00 | 666,666 | 9,999,990 | 2,723,509 | 2.1 M to 2.7 M (+32.41 %) |
| Oct 02 2018 | STRO | SUTRO BIOPHARMA IN ... | Merck & Co., Inc. | 10% Owner | Buy | C | 0.00 | 2,056,843 | 0 | 2,056,843 | 0 to 2.1 M |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 18,698,578 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,449,318 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 12,387,324 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 10,201,769 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 514,211 | 0 | 1,944,901 | 1.4 M to 1.9 M (+35.94 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 382,698 | 0 | 1,430,690 | 1 M to 1.4 M (+36.52 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 458,331 | 0 | 1,047,992 | 589.7 K to 1 M (+77.73 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 589,661 | 0 | 589,661 | 0 to 589.7 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 193,492 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 141,249 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 194,786 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 9,155,794 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,683,697 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 9,217,015 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 52,183 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 106,019 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 17,533 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 5,462,550 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,097,596 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,835,270 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 64,815 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 131,683 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 21,776 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | M | 0.00 | 4,978 | 0 | 52,183 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | M | 0.48 | 4,978 | 2,388 | 4,315 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | M | 0.00 | 521,159 | 0 | 5,462,550 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | M | 0.48 | 521,159 | 250,000 | 451,869 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | M | 0.00 | 6,183 | 0 | 64,815 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Option Exercise | M | 0.48 | 6,183 | 2,966 | 5,361 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 5,320 | 0 | 18,248 | 12.9 K to 18.2 K (+41.15 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 5,721 | 0 | 12,928 | 7.2 K to 12.9 K (+79.38 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 7,207 | 0 | 7,207 | 0 to 7.2 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 251,783 | 0 | 863,503 | 611.7 K to 863.5 K (+41.16 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 270,690 | 0 | 611,720 | 341 K to 611.7 K (+79.37 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 341,030 | 0 | 341,030 | 0 to 341 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 1,931 | 0 | 8,817 | 6.9 K to 8.8 K (+28.04 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 6,128 | 0 | 6,886 | 758 to 6.9 K (+808.44 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 758 | 0 | 758 | 0 to 758 |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 202,115 | 0 | 923,022 | 720.9 K to 923 K (+28.04 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 641,440 | 0 | 720,907 | 79.5 K to 720.9 K (+807.18 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 79,467 | 0 | 79,467 | 0 to 79.5 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 2,399 | 0 | 10,952 | 8.6 K to 11 K (+28.05 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 7,610 | 0 | 8,553 | 943 to 8.6 K (+807.00 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 943 | 0 | 943 | 0 to 943 |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 193,492 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 141,249 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 194,786 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 9,155,794 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 6,683,697 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 9,217,015 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 52,183 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 106,019 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 17,533 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 5,462,550 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 11,097,596 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 1,835,270 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 64,815 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 131,683 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 21,776 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.00 | 4,978 | 0 | 52,183 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.48 | 4,978 | 2,388 | 4,315 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.00 | 521,159 | 0 | 5,462,550 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.48 | 521,159 | 250,000 | 451,869 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.00 | 6,183 | 0 | 64,815 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.48 | 6,183 | 2,966 | 5,361 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 5,320 | 0 | 18,248 | 12.9 K to 18.2 K (+41.15 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 5,721 | 0 | 12,928 | 7.2 K to 12.9 K (+79.38 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 7,207 | 0 | 7,207 | 0 to 7.2 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 251,783 | 0 | 863,503 | 611.7 K to 863.5 K (+41.16 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 270,690 | 0 | 611,720 | 341 K to 611.7 K (+79.37 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 341,030 | 0 | 341,030 | 0 to 341 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 1,931 | 0 | 8,817 | 6.9 K to 8.8 K (+28.04 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 6,128 | 0 | 6,886 | 758 to 6.9 K (+808.44 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 758 | 0 | 758 | 0 to 758 |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 202,115 | 0 | 923,022 | 720.9 K to 923 K (+28.04 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 641,440 | 0 | 720,907 | 79.5 K to 720.9 K (+807.18 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 79,467 | 0 | 79,467 | 0 to 79.5 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 2,399 | 0 | 10,952 | 8.6 K to 11 K (+28.05 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 7,610 | 0 | 8,553 | 943 to 8.6 K (+807.00 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 943 | 0 | 943 | 0 to 943 |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Petree Daniel H | Director | Option Exercise | M | 5.81 | 314 | 1,824 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Petree Daniel H | Director | Sell | S | 15.00 | 122 | 1,830 | 192 | 314 to 192 (-38.85 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Petree Daniel H | Director | Buy | M | 5.81 | 314 | 1,824 | 314 | 0 to 314 |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Option Exercise | C | 0.00 | 192,267 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Option Exercise | C | 0.00 | 55,657 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Buy | C | 0.00 | 2,890 | 0 | 21,154 | 18.3 K to 21.2 K (+15.82 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Buy | C | 0.00 | 7,787 | 0 | 188,170 | 180.4 K to 188.2 K (+4.32 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Buy | C | 0.00 | 2,059 | 0 | 180,383 | 178.3 K to 180.4 K (+1.15 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 18,698,578 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 9,449,318 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 12,387,324 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 10,201,769 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 514,211 | 0 | 1,944,901 | 1.4 M to 1.9 M (+35.94 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 382,698 | 0 | 1,430,690 | 1 M to 1.4 M (+36.52 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 458,331 | 0 | 1,047,992 | 589.7 K to 1 M (+77.73 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 589,661 | 0 | 589,661 | 0 to 589.7 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Hallam Trevor | Chief Science Offic ... | Option Exercise | C | 0.00 | 50,033 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Hallam Trevor | Chief Science Offic ... | Buy | C | 0.00 | 2,026 | 0 | 15,800 | 13.8 K to 15.8 K (+14.71 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 18,698,578 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 12,846,023 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 25,015,635 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Freund John Gordon | Director | Buy | C | 0.00 | 514,211 | 0 | 1,960,053 | 1.4 M to 2 M (+35.56 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Freund John Gordon | Director | Buy | C | 0.00 | 520,264 | 0 | 1,445,842 | 925.6 K to 1.4 M (+56.21 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Freund John Gordon | Director | Buy | C | 0.00 | 925,578 | 0 | 925,578 | 0 to 925.6 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | C | 0.00 | 48,595 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | C | 0.00 | 94,633 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | FITZPATRICK LINDA A | Chief People & Comm ... | Option Exercise | C | 0.00 | 85,015 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | C | 0.00 | 1,968 | 0 | 10,383 | 8.4 K to 10.4 K (+23.39 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | C | 0.00 | 3,501 | 0 | 8,415 | 4.9 K to 8.4 K (+71.25 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | FITZPATRICK LINDA A | Chief People & Comm ... | Buy | C | 0.00 | 4,914 | 0 | 4,914 | 0 to 4.9 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | ALBINI EDWARD C | CFO and Secretary | Option Exercise | C | 0.00 | 41,694 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | ALBINI EDWARD C | CFO and Secretary | Buy | C | 0.00 | 1,688 | 0 | 1,688 | 0 to 1.7 K |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | Worsley Stephen | Chief Business Offi ... | Option Exercise | A | 15.00 | 203,056 | 3,045,840 | 203,056 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | Petree Daniel H | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Option Exercise | A | 0.00 | 75,757 | 0 | 75,757 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | NEWELL WILLIAM J | CEO & President | Option Exercise | A | 15.00 | 454,545 | 6,818,175 | 454,545 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | A | 0.00 | 25,826 | 0 | 25,826 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | MOLINA ARTURO MD | Chief Medical Offic ... | Option Exercise | A | 15.00 | 154,958 | 2,324,370 | 154,958 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | Lobacki Joseph M | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | LAWLIS V BRYAN | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | Hallam Trevor | Chief Science Offic ... | Option Exercise | A | 0.00 | 13,774 | 0 | 13,774 |